GAMA Healthcare, a leader in the manufacture and development of infection prevention products for the healthcare sector, has outlined plans to build a new research and development facility in the Greetland area of Halifax.
The proposed development, spread across 11,765 sq ft, is projected to cost £2 million and comprises a contemporary open-office environment with advanced research laboratories and auxiliary space to produce and test product samples.
Managing director and co-founder of GAMA Healthcare, Dr Guy Braverman said: “Plans for the new R&D facility are geared towards facilitating an up-to-date environment for research and innovation breakthroughs with industry leading practices. The laboratories will be capable of conducting detailed up-to-date research in all aspects of microbiology, infection control and analytical chemistry. A pilot plant is being incorporated to allow experimental small product runs enabling our teams to conduct trials and be proactive with quality assurance and internal testing. The facility will also incorporate a mock hospital room to replicate real life scenarios.”
